AAP
Ardsley Advisory Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-110,450
| Closed | -$9.19M | – | 135 |
|
|
2022
Q4 | $9.19M | Buy |
110,450
+35,000
| +46% | +$2.91M | 1.9% | 17 |
|
|
2022
Q3 | $6M | Buy |
+75,450
| New | +$6M | 1.34% | 23 |
|
|
2022
Q2 | – | Sell |
-135,000
| Closed | -$12.1M | – | 143 |
|
|
2022
Q1 | $12.1M | Buy |
135,000
+45,000
| +50% | +$4.04M | 2.02% | 9 |
|
|
2021
Q4 | $10.1M | Buy |
+90,000
| New | +$10.1M | 1.92% | 14 |
|
|
2020
Q3 | – | Sell |
-4,850
| Closed | -$543K | – | 166 |
|
|
2020
Q2 | $543K | Sell |
4,850
-90,150
| -95% | -$10.1M | 0.12% | 73 |
|
|
2020
Q1 | $7.36M | Sell |
95,000
-15,000
| -14% | -$1.16M | 2.88% | 11 |
|
|
2019
Q4 | $10.5M | Buy |
+110,000
| New | +$10.5M | 1.67% | 16 |
|
|
2019
Q3 | – | Sell |
-7,500
| Closed | -$658K | – | 163 |
|
|
2019
Q2 | $658K | Sell |
7,500
-57,500
| -88% | -$5.04M | 0.1% | 66 |
|
|
2019
Q1 | $5.89M | Buy |
65,000
+60,500
| +1,344% | +$5.48M | 1.13% | 25 |
|
|
2018
Q4 | $323K | Sell |
4,500
-2,500
| -36% | -$179K | 0.08% | 74 |
|
|
2018
Q3 | $671K | Sell |
7,000
-105,000
| -94% | -$10.1M | 0.09% | 72 |
|
|
2018
Q2 | $10.7M | Sell |
112,000
-126,500
| -53% | -$12M | 1.6% | 21 |
|
|
2018
Q1 | $20.9M | Sell |
238,500
-39,000
| -14% | -$3.42M | 3.14% | 4 |
|
|
2017
Q4 | $23.5M | Buy |
277,500
+9,500
| +4% | +$806K | 2.86% | 3 |
|
|
2017
Q3 | $23.2M | Sell |
268,000
-8,000
| -3% | -$693K | 3.09% | 4 |
|
|
2017
Q2 | $21.3M | Buy |
276,000
+56,500
| +26% | +$4.36M | 3.32% | 5 |
|
|
2017
Q1 | $15.2M | Buy |
219,500
+212,000
| +2,827% | +$14.7M | 2.36% | 7 |
|
|
2016
Q4 | $444K | Sell |
7,500
-2,500
| -25% | -$148K | 0.07% | 82 |
|
|
2016
Q3 | $663K | Buy |
10,000
+3,000
| +43% | +$199K | 0.1% | 72 |
|
|
2016
Q2 | $379K | Sell |
7,000
-3,000
| -30% | -$162K | 0.07% | 84 |
|
|
2016
Q1 | $517K | Buy |
10,000
+5,000
| +100% | +$259K | 0.08% | 68 |
|
|
2015
Q4 | $351K | Buy |
+5,000
| New | +$351K | 0.05% | 84 |
|
|
2014
Q2 | – | Sell |
-2,500
| Closed | -$356K | – | 271 |
|
|
2014
Q1 | $356K | Buy |
+2,500
| New | +$356K | 0.05% | 142 |
|